| # | Drug | Count |
|---|---|---|
| 0 | SELUMETINIB | 25 |
| 1 | PAZOPANIB HYDROCHLORIDE | 17 |
| 2 | HYDROCHLOROTHIAZIDE | 14 |
| 3 | IPILIMUMAB | 14 |
| 4 | AMLODIPINE | 13 |
| 5 | IRBESARTAN | 13 |
| 6 | PANTOPRAZOLE | 13 |
| 7 | PAZOPANIB | 13 |
| 8 | PREDNISONE | 13 |
| 9 | TACROLIMUS | 13 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | SELUMETINIB | 25 | 0.0148 |
| 1 | ALMOTRIPTAN | 4 | 0.0038 |
| 2 | NALDEMEDINE | 2 | 0.0012 |
| 3 | HISTRELIN ACETATE | 1 | 0.0011 |
| 4 | LAROTRECTINIB | 1 | 0.0011 |
| 5 | PSYLLIUM HUSK | 1 | 0.0007 |
| 6 | SELINEXOR | 6 | 0.0007 |
| 7 | PAZOPANIB HYDROCHLORIDE | 17 | 0.0006 |
| 8 | ENTRECTINIB | 1 | 0.0006 |
| 9 | GLUTATHIONE | 1 | 0.0006 |
| # | Drug class | Count |
|---|---|---|
| 0 | Kinase Inhibitor [EPC] | 31 |
| 1 | Corticosteroid [EPC] | 17 |
| 2 | CTLA-4-directed Blocking Antibody [EPC] | 14 |
| 3 | Thiazide Diuretic [EPC] | 14 |
| 4 | Angiotensin 2 Receptor Blocker [EPC] | 13 |
| 5 | Calcium Channel Blocker [EPC] | 13 |
| 6 | Dihydropyridine Calcium Channel Blocker [EPC] | 13 |
| 7 | Nonsteroidal Anti-inflammatory Drug [EPC] | 12 |
| 8 | beta-Adrenergic Blocker [EPC] | 12 |
| 9 | Alkylating Drug [EPC] | 7 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Nuclear Export Inhibitor [EPC] | 6 | 0.0007 |
| 1 | CTLA-4-directed Blocking Antibody [EPC] | 14 | 0.0003 |
| 2 | Neonatal Fc Receptor Blocker [EPC] | 1 | 0.0002 |
| 3 | GLP-2 Analog [EPC] | 2 | 0.0001 |
| 4 | Provitamin D2 Compound [EPC] | 4 | 0.0001 |
| 5 | Tissue-nonspecific Alkaline Phosphatase [EPC] | 1 | 0.0001 |
| 6 | Thiazide Diuretic [EPC] | 14 | 0.0001 |
| 7 | Kinase Inhibitor [EPC] | 31 | 0.0001 |
| 8 | Topoisomerase Inhibitor [EPC] | 4 | 0.0001 |
| 9 | Vitamin D3 Analog [EPC] | 1 | 0.0000 |